Abstract:ObjectiveTo evaluate the effectiveness and cost of the pan-London pharmacy initiative, a programme that allows administration of seasonal influenza vaccination to eligible patients at pharmacies.DesignWe analysed 2013–2015 data on vaccination uptake in pharmacies via the Sonar reporting system, and the total vaccination uptake via 2011–2015 ImmForm general practitioner (GP) reporting system data. We conducted an online survey of London pharmacists who participate in the programme to assess time use data, vacci… Show more
“…GPs were generally less positive about extended pharmacy services (Atkins et al., ; Latif et al., ; Porteous & Bond, ; Wilcock & Harding, ). Some GPs did not see extended pharmacy services as a priority for them (Wilcock & Harding, ), were not convinced that these services reduced their workload (Atkins et al., ; Latif et al., ; Porteous & Bond, ) and preferred services to be simplified (Porteous & Bond, ; Wilcock & Harding, ). Even when GPs were supportive of community pharmacy services (Blenkinsopp, Tann, Evans, & Grime, ; Michie, Cameron, Glasier, & Greed, ; Morecroft et al., ; Wilcock & Harding, ), this was associated with suggestions that they supervised and authorised pharmacists’ activities (Blenkinsopp et al., ; Bradley et al., ; Maddox, Halsall, Hall, & Tully, ; Michie et al., ).I guess we need to educate them, but I don't feel that's my responsibility…we're going to have to chase it up and make sure they are doing it properly.…”
Section: Resultsmentioning
confidence: 99%
“…They perceived the main benefit to GPs of extended pharmacy services was to reduce workload pressures (Agomo, Ogunleye, & Portlock, 2016a;Atkins et al, 2016;Morecroft et al, 2015;Pumtong et al, 2008), freeing up GPs time to deal with more urgent matters (Heller, Johnstone, & Cameron, 2017;Morecroft et al, 2015). In terms of their own benefit, most pharmacists viewed these services as an opportunity for role expansion/professional development, improving their relationships with patients (Butt & Ream, 2016;Campion et al, 2007;Latif et al, 2016;Paudyal et al, 2010;Pumtong et al, 2008;Urwin et al, 2016) and GPs (Agomo et al, 2016a;Pumtong et al, 2008).…”
Section: Perceived Value Of Services/rolesmentioning
confidence: 99%
“…(Pharmacist, Pumtong et al, 2008) GPs were generally less positive about extended pharmacy services (Atkins et al, 2016;Latif et al, 2016;Porteous & Bond, 2005;Wilcock & Harding, 2007). Some GPs did not see extended pharmacy services as a priority for them (Wilcock & Harding, 2007), were not convinced that these services reduced their workload (Atkins et al, 2016;Latif et al, 2016;Porteous & Bond, 2005) and preferred services to be simplified (Porteous & Bond, 2005;Wilcock & Harding, 2007).…”
Section: Perceived Value Of Services/rolesmentioning
confidence: 99%
“…In two studies, pharmacists highlighted the need to train locum pharmacists to provide the services on offer as many pharmacies hired them (Akram et al, 2012;Butt & Ream, 2016). GPs also often doubted pharmacists' competence to provide extended services (Atkins et al, 2016;Blenkinsopp et al, 2008;Bradley et al, 2012;Saramunee et al, 2014), expressing concerns with their ability to provide services beyond medicines management (Atkins et al, 2016;Blenkinsopp et al, 2008;Bradley et al, 2012;Saramunee et al, 2014).…”
Section: Pharmacists' Competence and Confidencementioning
There has been a strong policy emphasis over the past decade on optimising patient-centred care and reducing general practitioners' (GPs') workload by extending community pharmacy services and collaboration between pharmacists and GPs. Our aim was to review current evidence of pharmacists' and GPs' views of extended community pharmacy services and pharmacists' roles in the United Kingdom (UK). A systematic review was undertaken looking at UK studies investigating pharmacists' and/or GPs' views of community pharmacy services or roles from 2005 to 2017. A range of databases were searched including EMBASE, PubMed, Scopus, Web of Science, International Pharmaceutical Abstracts (IPA), PsycINFO, Science Direct and The Cumulative Index to Nursing and Allied Health Literature (CINAHL). In addition, reference lists of included studies were screened and grey literature was searched. Following the application of inclusion/exclusion criteria, the quality of papers was critically analysed, findings were extracted into a grid and subjected to narrative synthesis following thematic analysis. The search strategy yielded a total of 4,066 unique papers from which 60 were included. Forty-seven papers covered pharmacists' views, nine combined both pharmacists' and GPs' views and four covered GPs' views. Study designs included interviews (n = 31, 52%), questionnaire surveys (n = 17, 28%) and focus groups (n = 7, 12%). Three main themes emerged from the data: "attitudes towards services/roles", "community pharmacy organisations" and "external influences". Pharmacists and GPs perceived a number of barriers to successful implementation and integration of pharmacy services. Moreover, collaboration between pharmacists and GPs remains poor despite the introduction of extended services. Overall, extending community pharmacy services require quality-driven incentives and joint working between community pharmacists and GPs to achieve better integration within the patient's primary care pathway.
“…GPs were generally less positive about extended pharmacy services (Atkins et al., ; Latif et al., ; Porteous & Bond, ; Wilcock & Harding, ). Some GPs did not see extended pharmacy services as a priority for them (Wilcock & Harding, ), were not convinced that these services reduced their workload (Atkins et al., ; Latif et al., ; Porteous & Bond, ) and preferred services to be simplified (Porteous & Bond, ; Wilcock & Harding, ). Even when GPs were supportive of community pharmacy services (Blenkinsopp, Tann, Evans, & Grime, ; Michie, Cameron, Glasier, & Greed, ; Morecroft et al., ; Wilcock & Harding, ), this was associated with suggestions that they supervised and authorised pharmacists’ activities (Blenkinsopp et al., ; Bradley et al., ; Maddox, Halsall, Hall, & Tully, ; Michie et al., ).I guess we need to educate them, but I don't feel that's my responsibility…we're going to have to chase it up and make sure they are doing it properly.…”
Section: Resultsmentioning
confidence: 99%
“…They perceived the main benefit to GPs of extended pharmacy services was to reduce workload pressures (Agomo, Ogunleye, & Portlock, 2016a;Atkins et al, 2016;Morecroft et al, 2015;Pumtong et al, 2008), freeing up GPs time to deal with more urgent matters (Heller, Johnstone, & Cameron, 2017;Morecroft et al, 2015). In terms of their own benefit, most pharmacists viewed these services as an opportunity for role expansion/professional development, improving their relationships with patients (Butt & Ream, 2016;Campion et al, 2007;Latif et al, 2016;Paudyal et al, 2010;Pumtong et al, 2008;Urwin et al, 2016) and GPs (Agomo et al, 2016a;Pumtong et al, 2008).…”
Section: Perceived Value Of Services/rolesmentioning
confidence: 99%
“…(Pharmacist, Pumtong et al, 2008) GPs were generally less positive about extended pharmacy services (Atkins et al, 2016;Latif et al, 2016;Porteous & Bond, 2005;Wilcock & Harding, 2007). Some GPs did not see extended pharmacy services as a priority for them (Wilcock & Harding, 2007), were not convinced that these services reduced their workload (Atkins et al, 2016;Latif et al, 2016;Porteous & Bond, 2005) and preferred services to be simplified (Porteous & Bond, 2005;Wilcock & Harding, 2007).…”
Section: Perceived Value Of Services/rolesmentioning
confidence: 99%
“…In two studies, pharmacists highlighted the need to train locum pharmacists to provide the services on offer as many pharmacies hired them (Akram et al, 2012;Butt & Ream, 2016). GPs also often doubted pharmacists' competence to provide extended services (Atkins et al, 2016;Blenkinsopp et al, 2008;Bradley et al, 2012;Saramunee et al, 2014), expressing concerns with their ability to provide services beyond medicines management (Atkins et al, 2016;Blenkinsopp et al, 2008;Bradley et al, 2012;Saramunee et al, 2014).…”
Section: Pharmacists' Competence and Confidencementioning
There has been a strong policy emphasis over the past decade on optimising patient-centred care and reducing general practitioners' (GPs') workload by extending community pharmacy services and collaboration between pharmacists and GPs. Our aim was to review current evidence of pharmacists' and GPs' views of extended community pharmacy services and pharmacists' roles in the United Kingdom (UK). A systematic review was undertaken looking at UK studies investigating pharmacists' and/or GPs' views of community pharmacy services or roles from 2005 to 2017. A range of databases were searched including EMBASE, PubMed, Scopus, Web of Science, International Pharmaceutical Abstracts (IPA), PsycINFO, Science Direct and The Cumulative Index to Nursing and Allied Health Literature (CINAHL). In addition, reference lists of included studies were screened and grey literature was searched. Following the application of inclusion/exclusion criteria, the quality of papers was critically analysed, findings were extracted into a grid and subjected to narrative synthesis following thematic analysis. The search strategy yielded a total of 4,066 unique papers from which 60 were included. Forty-seven papers covered pharmacists' views, nine combined both pharmacists' and GPs' views and four covered GPs' views. Study designs included interviews (n = 31, 52%), questionnaire surveys (n = 17, 28%) and focus groups (n = 7, 12%). Three main themes emerged from the data: "attitudes towards services/roles", "community pharmacy organisations" and "external influences". Pharmacists and GPs perceived a number of barriers to successful implementation and integration of pharmacy services. Moreover, collaboration between pharmacists and GPs remains poor despite the introduction of extended services. Overall, extending community pharmacy services require quality-driven incentives and joint working between community pharmacists and GPs to achieve better integration within the patient's primary care pathway.
“…Since 2015 the public funds in the United Kingdom cover the expenses of influenza vaccinations of high-risk groups in pharmacies. Previous studies show that this leads to an increase of the number of vaccinated patients (Warner et al 2013), while ensuring lower costs for vaccinations in comparison with the traditional approaches (Atkins et al 2016). In 2015 more than 500 000 patients in the UK were vaccinated in the pharmacies, while not a single case of harm caused to a patient was reported (Wright 2016).…”
Value-added pharmacy services (VAPS) are additional services to the traditional pharmacy activities, which do not include dispensing of medicinal products and professional consultation. Over 51% of the community pharmacies in Bulgaria offer VAPS but mainly measuring of blood pressure (67.4%) and blood glucose (12.9%). About 60% of community pharmacists in the country are willing to perform other VAPS. About 70% of them believe that patients would rate VAPS as useful. Younger pharmacists with professional experience less than 5 years (90.9%) tend to believe that VAPS would be positively rated by their patients. The study shows that VAPS different from consultation and dispensing of medicinal products have a potential for development in the community pharmacies in Bulgaria.
BackgroundCommunity pharmacists have become flu vaccine immunisers in several countries to increase vaccine uptake.AimThis study aimed to perform a scoping review to evaluate the pharmacist's role and contribution to flu immunisation coverage, satisfaction and promotion as vaccine providers.DesignThe framework proposed by Arksey and O'Malley and the PRISMA Extension for Scoping Reviews (PRISMA‐ScR) were considered for this analysis. Two electronic databases (PubMed and Cochrane Library) were used to search for relevant peer‐reviewed quantitative, qualitative and mixed‐method studies published between 1990 and 2022.ResultsA total of 37 studies were included. These studies suggested that, over time, there was an increase in the rate of vaccine administration within community pharmacies across the various countries examined. Moreover, patients have consistently expressed their satisfaction with the convenience and accessibility of pharmacy‐based vaccine services, with some expressing a preference for pharmacies over traditional visits to their general practitioner′s office.ConclusionSeveral initiatives aimed at promoting flu vaccination have been rolled out in pharmacy settings, and a number of these initiatives have demonstrated positive outcomes. The flu vaccination service provided by pharmacists has proven to be an asset in public health by improving accessibility to immunisation services. Pharmacists should continue to take part in yearly flu vaccination programs as flu vaccine providers as they contribute to an increased uptake of immunisations by the population. Extending these services to other vaccines should be further considered.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
